GlyCardial Diagnostics is a spin-off company of the Catalan Institute of Cardiovascular Sciences (ICCC) and the Spanish National Research Council (CSIC) focused on the development of a novel in vitro diagnostic device for myocardial ischemia. The technology is based on the detection of Apo J-Glyc in blood as a biomarker for the early diagnosis of cardiac ischemia and the prediction of patient’s evolution after an ischemic event. GlyCardial Diagnostics was created by scientists Lina Badimon, Judit Cubedo, Teresa Padró and Gemma Vilahur. The company is located at the Hospital de la Santa Creu i Sant Pau Art Nouveau Site in Barcelona. In 2014, it was recognised as one of the most original, impactful technology projects in Spain in the MIT Technology Review awards for innovators under 35.
View Top Employees from GlyCardial DiagnosticsWebsite | http://www.glycardial.com/ |
Employees | 6 (6 on RocketReach) |
Founded | 2017 |
Phone | +34 935 56 58 85 |
Technologies |
JavaScript,
HTML,
PHP
+22 more
(view full list)
|
Industry | Biotechnology, Diagnostic Equipment, Science and Engineering, Health Care, Health Diagnostics, Life Science, Medical Device, Pharmaceutical |
Looking for a particular GlyCardial Diagnostics employee's phone or email?
Juan-Carlos Kaski is the Medical Director of GlyCardial Diagnostics.
6 people are employed at GlyCardial Diagnostics.